The common variant of rs6214 in insulin like growth factor 1 (IGF1) gene: a potential protective factor for non-alcoholic fatty liver disease

References

• Araujo, A.R., et al., 2018. Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: what we need in the future. Liver international, 38, 47–51.
   PubMed Web of Science ®Google Scholar
• Atay, K., et al., 2017. Apoptosis and disease severity is associated with insulin resistance in non-alcoholic fatty liver disease. Acta gastro-enterologica belgica, 80 (2), 271–277.
   PubMed Web of Science ®Google Scholar
• Brunt, E. M., et al., 2009. Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a  histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network. Hepatology, 49 (3), 809–820. doi:10.1002/hep.22724
   PubMed Web of Science ®Google Scholar
• Barroso, M.C., et al., 2016. Serum insulin-like growth factor-1 and its binding protein-7: potential novel biomarkers for heart failure with preserved ejection fraction. BMC cardiovascular disorders, 16 (1), 199.
   PubMedGoogle Scholar
• Bellentani, S., et al., 2010. Epidemiology of non-alcoholic fatty liver disease. Digestive diseases (Basel, Switzerland)), 28 (1), 155–161.
   PubMed Web of Science ®Google Scholar
• Brunt, E.M., et al., 1999. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. The American journal of gastroenterology, 94 (9), 2467–2474.
   PubMed Web of Science ®Google Scholar
• Chen, J.M., et al., 2006. A systematic analysis of disease-associated variants in the 3' regulatory regions of human protein-coding genes I: general principles and overview. Human genetics, 120 (1), 1–21.
   PubMed Web of Science ®Google Scholar
• Chishima, S., et al., 2017. The relationship between the growth hormone/insulin-like growth factor system and the histological features of nonalcoholic fatty liver disease. Internal medicine, 56 (5), 473–480.
   PubMed Web of Science ®Google Scholar
• Colak, Y., et al., 2012. Serum concentrations of human insulin-like growth factor-1 and levels of insulin-like growth factor-binding protein-5 in patients with nonalcoholic fatty liver disease: association with liver histology. European journal of gastroenterology and hepatology, 24 (3), 255–261.
   PubMed Web of Science ®Google Scholar
• Conne, B., et al., 2000. The 3' untranslated region of messenger RNA: a molecular “hotspot” for pathology? Nature medicine, 6 (6), 637–641.
   PubMed Web of Science ®Google Scholar
• D’Aloisio, A.A., et al., 2009. IGF-I and IGFBP-3 polymorphisms in relation to circulating levels among African American and Caucasian women. Cancer epidemiology, biomarkers and prevention, 18, 954–966.
   PubMed Web of Science ®Google Scholar
• Dietrich, P., and Hellerbrand, C., 2014. Non-alcoholic fatty liver disease, obesity and the metabolic syndrome. Best practice and research. Clinical gastroenterology, 28 (4), 637–653.
   Google Scholar
• Donaghy, A., et al., 1997. Growth hormone therapy in patients with cirrhosis: a pilot study of efficacy and safety. Gastroenterology, 113 (5), 1617–1622.
   PubMed Web of Science ®Google Scholar
• Dongiovanni, P., et al., 2010. Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease. Gut, 59 (2), 267–273.
   PubMed Web of Science ®Google Scholar
• Eguchi, Y., et al., 2006. Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease. Journal of gastroenterology, 41 (5), 462–469.
   PubMed Web of Science ®Google Scholar
• Federici, M., 1998. Increased abundance of insulin/insulin-like growth factor-I hybrid receptors in skeletal muscle of obese subjects is correlated with in vivo insulin sensitivity. Journal of clinical endocrinology and metabolism, 83 (8), 2911–2915.
   PubMed Web of Science ®Google Scholar
• Fujii, H., et al.,; Japan Study Group of Nonalcoholic Fatty Liver Disease. 2019. HOMA-IR: an independent predictor of advanced liver fibrosis in nondiabetic non-alcoholic fatty liver disease. Journal of gastroenterology and hepatology, 34 (8), 1390–1395.
   PubMed Web of Science ®Google Scholar
• Gholam, P.M., et al., 2007. Nonalcoholic fatty liver disease in severely obese subjects. The American journal of gastroenterology, 102 (2), 399–408.
   PubMed Web of Science ®Google Scholar
• Giovannucci, E., 2001. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. The journal of nutrition, 131 (11 Suppl), 3109S–3120S.
   PubMed Web of Science ®Google Scholar
• Grijalva-Avila, J., et al., 2020. Milk intake and IGF-1 rs6214 polymorphism as protective factors to obesity. International journal of food sciences and nutrition, 71 (3), 388–393.
   PubMed Web of Science ®Google Scholar
• Harrela, M., et al., 1996. Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. Journal of clinical investigation, 98 (11), 2612–2615.
   PubMed Web of Science ®Google Scholar
• Haukeland, J.W., et al., 2005. Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease. Scandinavian journal of gastroenterology, 40 (12), 1469–1477.
   PubMed Web of Science ®Google Scholar
• He, B., et al., 2019. Prenatal caffeine exposure induces liver developmental dysfunction in offspring rats. The journal of endocrinology, 242 (3), 211–226.
   PubMed Web of Science ®Google Scholar
• Hribal, M.L., et al., 2013. Insulin-like growth factor-I, inflammatory proteins, and fibrosis in subjects with nonalcoholic fatty liver disease. The journal of clinical endocrinology and metabolism, 98 (2), E304–308.
   PubMed Web of Science ®Google Scholar
• Hung, T.M., et al., 2014. Up-regulation of microRNA-190b plays a role for decreased IGF-1 that induces insulin resistance in human hepatocellular carcinoma. Plos one, 9 (2), e89446.
   PubMed Web of Science ®Google Scholar
• Ichikawa, T., et al., 2007. Role of growth hormone, insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 in development of non-alcoholic fatty liver disease. Hepatology international, 1 (2), 287–294.
   PubMed Web of Science ®Google Scholar
• Kuroda, A., et al., 2009. Insulin gene expression is regulated by DNA methylation. Plos one, 4 (9), e6953.
   PubMed Web of Science ®Google Scholar
• Li, M., et al., 2015. Prevalence of insulin resistance in subjects with nonalcoholic fatty liver disease and its predictors in a Chinese population. Digestive diseases and sciences, 60 (7), 2170–2176.
   PubMed Web of Science ®Google Scholar
• Mallea-Gil, M.S., et al., 2012. IGF-1 levels in different stages of liver steatosis and its association with metabolic syndrome. Acta gastroenterologica LatinoAmericana, 42, 20–26.
   PubMedGoogle Scholar
• Nishizawa, H., et al., 2012. GH-independent IGF-I action is essential to prevent the development of nonalcoholic steatohepatitis in a GH-deficient rat model. Biochemical and biophysical research communications, 423 (2), 295–300.
   PubMed Web of Science ®Google Scholar
• Ohmi, S., et al., 2017. Analysis of factors influencing glucose tolerance in Japanese patients with non-alcoholic fatty liver disease. Diabetology and metabolic syndrome, 9, 65.
   PubMed Web of Science ®Google Scholar
• Patel, A.V., et al., 2008. Breast and Prostate Cancer Cohort Consortium. IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3). Plos one., 3 (7), e2578.
   PubMed Web of Science ®Google Scholar
• Salamone, F., and Bugianesi, E., 2010. Nonalcoholic fatty liver disease: the hepatic trigger of the metabolic syndrome. Journal of hepatology, 53 (6), 1146–1147.
   PubMed Web of Science ®Google Scholar
• Sandhu, M.S., et al., 2002. Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study. The lancet, 359 (9319), 1740–1745.
   PubMed Web of Science ®Google Scholar
• Schäfer, S.A., et al., 2011. New type 2 diabetes risk genes provide new insights in insulin secretion mechanisms. Diabetes research and clinical practice, 93, S9–S24.
   PubMed Web of Science ®Google Scholar
• Siddiqui, M.S., et al., 2015. Severity of nonalcoholic fatty liver disease and progression to cirrhosis are associated with atherogenic lipoprotein profile. Clinical Gastroenterology and Hepatology, 13 (5), 1000–1008.
   PubMed Web of Science ®Google Scholar
• Succurro, E., et al., 2009. Low plasma insulin-like growth factor-1 levels are associated with reduced insulin sensitivity and increased insulin secretion in nondiabetic subjects. Nutrition, metabolism, and cardiovascular diseases : Nmcd, 19 (10), 713–719.
   PubMed Web of Science ®Google Scholar
• Sumida, Y., et al., 2015. Lower levels of insulin-like growth factor-1 standard deviation score are associated with histological severity of non-alcoholic fatty liver disease. Hepatology research, 45 (7), 771–781.
   PubMed Web of Science ®Google Scholar
• Tan, Y., et al., 2012. Caffeine-induced fetal rat over-exposure to maternal glucocorticoid and histone methylation of liver IGF-1 might cause skeletal growth retardation. Toxicology letters, 214 (3), 279–287.
   PubMed Web of Science ®Google Scholar
• Vaessen, N., et al., 2001. A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes, 50 (3), 637–642.
   PubMed Web of Science ®Google Scholar
• Wang, L., et al., 2014. Intrauterine metabolic programming alteration increased susceptibility to non-alcoholic adult fatty liver disease in prenatal caffeine-exposed rat offspring. Toxicology letters, 224 (3), 311–318.
   PubMed Web of Science ®Google Scholar
• Wang, R., et al., 2017. Microsatellite and single nucleotide polymorphisms in the insulin-like growth factor 1 promoter with insulin sensitivity and insulin secretion. Medical science monitor : international medical journal of experimental and clinical research, 23, 3722–3736.
   PubMed Web of Science ®Google Scholar
• Willems, S.M., et al., 2016. Association of the IGF1 gene with fasting insulin levels. European journal of human genetics:Ejhg, 24 (9), 1337–1343.
   PubMed Web of Science ®Google Scholar
• Xu, M., et al., 2018. MicroRNA-190b regulates lipid metabolism and insulin sensitivity by targeting IGF-1 and ADAMTS9 in non-alcoholic fatty liver disease. Journal of cellular biochemistry, 119 (7), 5864–5874.
   PubMed Web of Science ®Google Scholar
• Yakar, S., et al., 2001. Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity. Diabetes, 50 (5), 1110–1118.
   PubMed Web of Science ®Google Scholar
• Yan, H., et al., 2019. Insulin-like growth factor binding protein 7 accelerates hepatic steatosis and insulin resistance in non-alcoholic fatty liver disease. Clinical and experimental pharmacology and physiology, 46 (12), 1101–1110.
   PubMed Web of Science ®Google Scholar
• Yang, C.W., et al., 2015. Insulinlike growth factor-1 and its binding protein-3 polymorphisms predict circulating IGF-1 level and appendicular skeletal muscle mass in Chinese elderly. Journal of the American medical directors association, 16 (5), 365–3670.
   PubMed Web of Science ®Google Scholar
• Yao, Y., et al., 2019. Insulin-like growth factor-1 and non-alcoholic fatty liver disease: a systemic review and meta-analysis. Endocrine, 65 (2), 227–237.
   PubMed Web of Science ®Google Scholar